Natrol

Melatonin TR Time Release 5 mg

C+
N+ Score74
Sleep & RecoveryServing: 1 Tablet(s)Type: Other Combinations

Natrol's Melatonin TR Time Release 5 mg is an 'Other Combinations' supplement for Sleep & Recovery, receiving an N+ Score of 74 and a C+ grade, indicating good product quality. This product contains 2 ingredients, both clearly disclosed. It provides 5 mg of Melatonin, Synthetic, alongside Vitamin B6 at a clinically relevant dosage of 10 mg. The time-release formulation is designed to support sustained melatonin delivery. This supplement may be suitable for individuals seeking to support sleep onset and maintenance, particularly those who may benefit from a combination of melatonin and vitamin B6.

About This Product

Melatonin TR Time Release 5 mg by Natrol is a sleep & recovery supplement containing 2 active ingredients. It has earned an N+ Score of 74/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Vitamin B6.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness25/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • −Missing several expected ingredients for its category

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Vitamin B610.000 mgOptimal
Melatonin, Synthetic5.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.